Clinical trialPhase 1Not yet recruiting
NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer
A Phase I Study of NH002-mediated Sonoporation With Nanoliposomal Irinotecan, Leucovorin, and 5-Fluorouracil in Pancreatic Ductal Adenocarcinoma Patients With Liver Metastasis
- Outcome
- Ongoing
- Phase
- Phase 1
- Status
- Not yet recruiting
- Study type
- Interventional
- Start
- 1 January 2026
- Expected end
- 31 December 2027
- Enrollment
- 24 participants
- Sites
- 1
- Primary outcomes
- AE; MTD
- Sponsor
- Other
- Results posted
- No
- Last update
- 2 January 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 3
- BackgroundClinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, … DOI 10.1007/s00330-023-10210-4↗
- BackgroundA human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- BackgroundNanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-… DOI 10.1016/s0140-6736(15)00986-1↗